Please use this identifier to cite or link to this item: https://doi.org/10.1186/1471-2369-8-7
DC FieldValue
dc.titleFibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy
dc.contributor.authorJavaid, M.M
dc.contributor.authorDenley, H
dc.contributor.authorTagboto, S
dc.date.accessioned2020-10-20T04:46:43Z
dc.date.available2020-10-20T04:46:43Z
dc.date.issued2007
dc.identifier.citationJavaid, M.M, Denley, H, Tagboto, S (2007). Fibrillary glomerulonephritis with small fibrils in a patient with the antiphospholipid antibody syndrome successfully treated with immunosuppressive therapy. BMC Nephrology 8 : 7. ScholarBank@NUS Repository. https://doi.org/10.1186/1471-2369-8-7
dc.identifier.issn14712369
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/177995
dc.description.abstractBackground. Fibrillary glomerulonephritis is a rare cause of progressive renal dysfunction, often leading to the need for dialysis within a few years. The role of immunosuppressive treatment is still uncertain although this has been tried with variable success. Case presentation. A 56 year old woman with the antiphospholipid antibody syndrome (IgM anticardiolipin antibodies) was seen in the nephrology clinic with haematuria, proteinuria, and worsening renal function. A renal biopsy demonstrated a mesangial proliferative glomerulonephritis on light microscopy and smaller fibrils (10.6-13.8 nm in diameter) than is usual for fibrillary glomerulonephritis (typically 18-22 nm) on electron microscopy. Amyloidosis was excluded following detailed evaluation. On account of rapidly worsening renal failure she was started on cyclophosphamide and prednisolone which led to the partial recovery and stabilization of her renal function. Conclusion. This case highlights the need for routine electron microscopy in native renal biopsies, where the differential diagnosis is wide and varied and the light and immunofluorescence microscopic findings may be non specific. © 2007 Javaid et al; licensee BioMed Central Ltd.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjectamlodipine
dc.subjectatorvastatin
dc.subjectcardiolipin antibody
dc.subjectcyanocobalamin
dc.subjectcyclophosphamide
dc.subjecterythropoietin
dc.subjectimmunoglobulin M antibody
dc.subjectiron
dc.subjectperindopril
dc.subjectprednisolone
dc.subjectwarfarin
dc.subjectcyclophosphamide
dc.subjectimmunosuppressive agent
dc.subjectprednisolone
dc.subjectadult
dc.subjectanamnesis
dc.subjectantiphospholipid syndrome
dc.subjectarticle
dc.subjectcase report
dc.subjectclinical evaluation
dc.subjectclinical feature
dc.subjectcreatinine blood level
dc.subjectdiagnostic imaging
dc.subjectdisease association
dc.subjectdisease course
dc.subjectdrug dose reduction
dc.subjectdrug effect
dc.subjectelectron microscopy
dc.subjectfemale
dc.subjectfiber
dc.subjectfibrillary glomerulonephritis
dc.subjectglomerulonephritis
dc.subjectglomerulus
dc.subjecthematuria
dc.subjecthuman
dc.subjecthuman cell
dc.subjecthuman tissue
dc.subjecthypertension
dc.subjectimmunosuppressive treatment
dc.subjectkidney biopsy
dc.subjectkidney failure
dc.subjectkidney function
dc.subjectnucleotide sequence
dc.subjectproliferative glomerulonephritis
dc.subjectproteinuria
dc.subjectantiphospholipid syndrome
dc.subjectdrug combination
dc.subjectmiddle aged
dc.subjecttreatment outcome
dc.subjectAntiphospholipid Syndrome
dc.subjectCyclophosphamide
dc.subjectDrug Combinations
dc.subjectFemale
dc.subjectGlomerulonephritis
dc.subjectHumans
dc.subjectImmunosuppressive Agents
dc.subjectMiddle Aged
dc.subjectPrednisolone
dc.subjectTreatment Outcome
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.doi10.1186/1471-2369-8-7
dc.description.sourcetitleBMC Nephrology
dc.description.volume8
dc.description.page7
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_1471-2369-8-7.pdf2.13 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons